- Home
- BRBR vs ABSI Comparison
BRBR vs ABSI Comparison
Compare BRBR & ABSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BRBR | ABSI |
|---|---|---|
| Founded | 2019 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Packaged Foods | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 997.8M |
| IPO Year | 2019 | 2021 |
Fundamental Metrics
Financial Performance| Metric | BRBR | ABSI |
|---|---|---|
| Price | $12.56 | $7.73 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 17 | 4 |
| Target Price | ★ $36.63 | $6.96 |
| AVG Volume (30 Days) | ★ 3.9M | 3.8M |
| Earning Date | 05-05-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 10.64 |
| EPS | ★ 0.65 | N/A |
| Revenue | ★ $2,316,600,000.00 | $4,534,000.00 |
| Revenue This Year | $6.28 | $215.96 |
| Revenue Next Year | $5.81 | $319.10 |
| P/E Ratio | $20.34 | ★ N/A |
| Revenue Growth | ★ 16.05 | N/A |
| 52 Week Low | $7.82 | $2.24 |
| 52 Week High | $54.65 | $12.06 |
Technical Indicators
Market Signals| Indicator | BRBR | ABSI |
|---|---|---|
| Relative Strength Index (RSI) | 55.51 | 41.93 |
| Support Level | $11.94 | $2.56 |
| Resistance Level | $14.29 | $12.06 |
| Average True Range (ATR) | 0.64 | 0.66 |
| MACD | -0.03 | -0.29 |
| Stochastic Oscillator | 45.09 | 24.24 |
Price Performance
Historical ComparisonAbout BRBR BellRing Brands Inc.
BellRing Brands Inc is a United States-based company engaged in providing nutrition-related products. Its brands, Premier Protein, Dymatize, and PowerBar provides various products including ready-to-drink protein shakes, powders and nutrition bars. The company's products are distributed through a diverse network of channel including club, food, drug and mass, eCommerce, convenience and specialty.
About ABSI Absci Corporation
Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process. Its lead product candidate, ABS-201, is an anti-prolactin receptor (PRLR) antibody engineered with an extended half-life to support a patient-friendly dosing interval.